These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8568546)

  • 41. Preclinical comparative evaluation of aminoglycosides.
    Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
    Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gentamicin-resistant gram-negative bacilli in hospital patients. Part II. In vitro aspects including susceptibility to tobramycin and amikacin.
    Block CS; Fabian B; Robinson RG
    S Afr Med J; 1978 Mar; 53(11):396-99. PubMed ID: 675374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacodynamic parameters of ofloxacin, tobramycin and ceftriaxone and their effect on the biological properties of salmonellae.
    Majtán V; Majtánová L
    Arzneimittelforschung; 1997 Sep; 47(9):1052-5. PubMed ID: 9342422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gentamicin resistance in Staphylococcus aureus.
    Porthouse A; Brown DF; Smith RG; Rogers T
    Lancet; 1976 Jan; 1(7949):20-1. PubMed ID: 54520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased bactericidal activity during the period of the postantibiotic effect.
    Gudmundsson S; Vogelman B; Craig WA
    J Antimicrob Chemother; 1994 Dec; 34(6):921-30. PubMed ID: 7730235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Study of the activity of a new glycopeptide antibiotic eremomycin combined with tobramycin against Staphylococci in vitro].
    Iakushkina IV; Malkova IV; Prozorova IN
    Antibiot Khimioter; 1988 May; 33(5):342-5. PubMed ID: 3415389
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postantibiotic leukocyte enhancement of meropenem against gram-positive and gram-negative strains.
    Novelli A; Fallani S; Cassetta MI; Conti S; Mazzei T
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3174-6. PubMed ID: 11036045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postantibiotic effect in Pseudomonas aeruginosa following single and multiple aminoglycoside exposures in vitro.
    Karlowsky JA; Zhanel GG; Davidson RJ; Hoban DJ
    J Antimicrob Chemother; 1994 May; 33(5):937-47. PubMed ID: 8089067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postantibiotic effect of aminoglycosides on gram-negative bacteria evaluated by a new method.
    Isaksson B; Nilsson L; Maller R; Sörén L
    J Antimicrob Chemother; 1988 Jul; 22(1):23-33. PubMed ID: 3139614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Once-daily aminoglycoside dosing assessed by MIC reversion time with Pseudomonas aeruginosa.
    Karlowsky JA; Zhanel GG; Davidson RJ; Hoban DJ
    Antimicrob Agents Chemother; 1994 May; 38(5):1165-8. PubMed ID: 8067757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensitivity of strains of enteropathogenic Escherichia coli to tobramycin and other antibiotics.
    Konforti N; Lev B; Hanner N
    Med Microbiol Immunol; 1977 Dec; 163(4):269-76. PubMed ID: 342889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Norfloxacin and ursolic acid: in vitro association and postantibiotic effect against Staphylococcus aureus.
    Filocamo A; Bisignano C; D'Arrigo M; Ginestra G; Mandalari G; Galati EM
    Lett Appl Microbiol; 2011 Aug; 53(2):193-7. PubMed ID: 21609344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In-vitro activity of LY 146032, a novel cyclic lipopeptide, alone and in combination with gentamicin or tobramycin against enterococci.
    Watanakunakorn C
    J Antimicrob Chemother; 1987 Apr; 19(4):445-8. PubMed ID: 3034849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancement of the susceptibility of Staphylococcus aureus to phagocytosis after treatment with fosfomycin compared with other antimicrobial agents.
    Pérez Fernández P; Herrera I; Martínez P; Gómez-Lus ML; Prieto J
    Chemotherapy; 1995; 41(1):45-9. PubMed ID: 7875021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 5-Methylindole Potentiates Aminoglycoside Against Gram-Positive Bacteria Including
    Sun F; Bian M; Li Z; Lv B; Gao Y; Wang Y; Fu X
    Front Cell Infect Microbiol; 2020; 10():84. PubMed ID: 32185144
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Laboratory and clinical evaluation of tobramycin, a new aminoglycoside antibiotic.
    Escárzaga E; Hill J; Ganzález S; Berruecos P; Luna M; Gutiérrez M
    J Infect Dis; 1976 Aug; 134 Suppl():S158-64. PubMed ID: 972275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postantibiotic suppression of bacterial growth.
    Bundtzen RW; Gerber AU; Cohn DL; Craig WA
    Rev Infect Dis; 1981; 3(1):28-37. PubMed ID: 6784225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gentamicin and tobramycin resistant gram-negative bacilli in a community hospital.
    Magnussen CR; Sammartino M
    Infect Control; 1980; 1(4):249-52. PubMed ID: 6905816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacodynamics of beta-lactam antibiotics. Studies on the paradoxical and postantibiotic effects in vitro and in an animal model.
    Odenholt-Tornqvist I
    Scand J Infect Dis Suppl; 1989; 58():1-55. PubMed ID: 2499924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperoxia prolongs the aminoglycoside-induced postantibiotic effect in Pseudomonas aeruginosa.
    Park MK; Muhvich KH; Myers RA; Marzella L
    Antimicrob Agents Chemother; 1991 Apr; 35(4):691-5. PubMed ID: 1906262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.